UFP Technologies Acquires UNIPEC and TPI to Expand Film and Thermoplastic Molding Capabilities
MWN-AI** Summary
On July 17, 2025, UFP Technologies, Inc. (Nasdaq: UFPT), based in Newburyport, Massachusetts, announced the acquisition of Universal Plastics & Engineering Company, Inc. (“UNIPEC”) and Techno Plastics Industries, Inc. (“TPI”). This strategic move aims to enhance UFP’s capabilities in tight tolerance film components and thermoplastic molding, specifically targeting the growing medical device market.
UNIPEC, located in Rockville, Maryland, specializes in precision thermoformed and heat-sealed polymer components, primarily used for battery shielding in Class III implantable medical devices. The acquisition is expected to strengthen UFP’s existing Welch Fluorocarbon operation, expanding its thin film platform and increasing production capacities for demanding applications in the implantable sector. UFP's Chairman and CEO, R. Jeffrey Bailly, expressed enthusiasm for the partnership, noting UNIPEC’s expertise as a perfect fit for enhancing their implantable device offerings.
TPI, based in Anasco, Puerto Rico, brings significant experience in thermoplastic injection molding. The company's operations contribute to UFP's existing capabilities and are particularly beneficial for clients already supported by UFP, underscoring the commitment to providing comprehensive solutions in medical device manufacturing. Bailly commented on TPI's strategic location near their Dominican Republic operations, which further solidifies their commitment to advanced medical solutions.
Financially, UNIPEC and TPI reported approximate revenues of $5 million and $10 million, respectively. Both acquisitions were financed through available cash and existing credit facilities. UFP Technologies aims to harness the unique technologies and leadership of these new additions to bolster its position within high-growth medical device sectors, enhancing its partnerships with leading OEMs in the industry.
MWN-AI** Analysis
UFP Technologies, Inc. (Nasdaq: UFPT) has taken a significant step forward with its recent acquisitions of Universal Plastics & Engineering Company, Inc. (UNIPEC) and Techno Plastics Industries, Inc. (TPI). This strategic move is aimed at enhancing UFP's capabilities in the high-growth medical device sector, particularly in the realms of tight tolerance film components and thermoplastic molding.
Investors should view these acquisitions positively, as they strengthen UFP’s existing product lines, especially in the challenging implantable medical devices market. UNIPEC's core competencies in precision thermoforming and heat-sealed polymer components provide a strategic fit, augmenting UFP’s existing Welch Fluorocarbon operation. This deepened expertise in specialty EMI shielding materials enhances UFP's value proposition to medical device original equipment manufacturers (OEMs).
Furthermore, TPI's established market presence and experience in thermoplastic injection-molded components, particularly in relation to robotic-assisted surgical solutions, positions UFP favorably in addressing customer needs across its existing client base. The consolidation of such capabilities not only promises to enhance operational efficiencies but also solidifies UFP's role as a key partner in a market characterized by demanding specifications and high regulatory hurdles.
Despite these promising developments, investors should remain cognizant of the inherent risks associated with the integration of acquired companies. Historically, successful integrations can take significant time and resources, and execution challenges could impact the short-term financial performance. The combined revenue of approximately $15 million against the backdrop of existing operations suggests a strategic but cautious expansion.
In conclusion, while UFP's strategic acquisitions of UNIPEC and TPI signal potential growth and an expanded market footprint, prudent investors should meticulously monitor the integration process and assess market conditions for medical device demand to gauge future performance accurately.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
NEWBURYPORT, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisitions of Universal Plastics & Engineering Company, Inc. (“UNIPEC”) and Techno Plastics Industries, Inc. (“TPI”). These transactions further expand UFP’s capabilities in tight tolerance film components and thermoplastic molding for the medical device market.
UNIPEC, headquartered in Rockville, Maryland, develops and manufactures precision thermoformed and heat-sealed polymer components used primarily for shielding batteries in Class III implantable medical devices. The company is an excellent strategic fit with UFP’s Welch Fluorocarbon operation, enhancing its thin film platform and increasing production scale for demanding implantable applications.
“We are excited to welcome UNIPEC to our growing portfolio of high-performance film solutions,” said R. Jeffrey Bailly, Chairman and CEO of UFP Technologies. “Their expertise in tight tolerance molding of specialty EMI shielding materials adds further strength to our implantable device offerings and complements Welch Fluorocarbon’s core capabilities.”
TPI, based in Anasco, Puerto Rico, is a specialty manufacturer of precision thermoplastic injection-molded components. “TPI brings deep expertise in engineering, tooling, and molding of medical device components and services a number of existing UFP clients – expanding on our commitment to create more value for our customers by adding complementary technologies to meet more of their needs,” explained Bailly.
“TPI is a strong strategic fit that bolsters our thermoplastic molding capabilities. They are strategically located near our DAS business in the Dominican Republic that utilizes a number of injection molded components in our robotic assisted surgery drape solutions,” said Bailly.
“These acquisitions further our strategy of expanding capabilities in high-growth, high-barrier sectors of the medical device market,” added Bailly. “Each company brings unique technologies, strong leadership, and deep application knowledge that will strengthen our partnerships with leading medical device OEMs.”
Transaction Financial Highlights
- UNIPEC has approximately $5 million in revenue and $2 million in EBITDA.
- TPI has approximately $10 million in revenue and $1 million in EBITDA.
- The transactions were financed with available cash and borrowings under UFP’s existing credit facility.
About UFP Technologies, Inc.
UFP Technologies is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device supply chain and a valued outsource partner to most of the top medical device manufacturers in the world. The Company’s single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.
Forward Looking Statements
This press release contains statements relating to expected financial performance and/or future business prospects, events, and plans that are forward-looking statements. Such statements include but are not limited to: the anticipated effects on us of acquiring UNIPEC and TPI; anticipated trends in the different markets in which we compete and expectations regarding customer demand; expectations regarding our business opportunities; and statements about our growth potential and strategies for growth. Investors are cautioned that such forward-looking statements involve risks and uncertainties that could adversely affect our business and prospects, and otherwise cause actual results to differ materially from those anticipated by such forward-looking statements, including the risks that the Company will not realize the anticipated benefits of the acquisition of UNIPEC and TPI due to the inability of the Company to execute its business strategy, UNIPEC and TPI integration strategy or otherwise as well as other risks and uncertainties that are detailed in the documents we file with the SEC. Accordingly, actual results may differ materially. Readers are referred to the documents we file with the SEC, specifically the last report on Form 10-K. The forward-looking statements contained herein speak only of our expectations as of the date of this press release. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statement to reflect any change in our expectations or any change in events, conditions, or circumstances on which any such statement is based.
Contact: Ron Lataille
978-234-0926, rlataille@ufpt.com
www.ufpt.com
FAQ**
How does UFP Technologies Inc. (UFPT) plan to integrate UNIPEC and TPI into its existing operations to maximize the benefits from these acquisitions?
What specific growth strategies does UFP Technologies Inc. (UFPT) foresee in the medical device market post-acquisition of UNIPEC and TPI?
Can UFP Technologies Inc. (UFPT) provide insights into how the acquisition of UNIPEC, with its focus on Class III implantable devices, enhances its competitive positioning?
How does UFP Technologies Inc. (UFPT) intend to mitigate the risks and uncertainties associated with the integration of UNIPEC and TPI as mentioned in the forward-looking statements?
**MWN-AI FAQ is based on asking OpenAI questions about UFP Technologies Inc. (NASDAQ: UFPT).
NASDAQ: UFPT
UFPT Trading
-1.46% G/L:
$202.055 Last:
131,771 Volume:
$206.22 Open:
